| Followers | 1 |
| Posts | 846 |
| Boards Moderated | 0 |
| Alias Born | 03/27/2022 |
Friday, October 18, 2024 7:21:13 AM
Pre market green and steady
Recent TVGN News
- Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth • GlobeNewswire Inc. • 03/26/2026 04:45:00 PM
- Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/25/2026 06:20:00 PM
- Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) • GlobeNewswire Inc. • 03/18/2026 04:22:11 PM
- Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization • GlobeNewswire Inc. • 03/13/2026 06:45:00 PM
- Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure • GlobeNewswire Inc. • 03/13/2026 04:30:00 PM
- Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform • GlobeNewswire Inc. • 03/11/2026 07:15:00 PM
- Tevogen Names Leadership Team to Execute Diversified Growth Strategy • GlobeNewswire Inc. • 03/09/2026 11:45:00 AM
- Letter to Shareholders from CEO Dr. Ryan Saadi • GlobeNewswire Inc. • 03/06/2026 08:40:00 PM
- Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical • GlobeNewswire Inc. • 03/05/2026 07:50:00 PM
- Tevogen Bio to implement 1-for-50 reverse stock split to regain Nasdaq compliance • IH Market News • 03/04/2026 03:47:21 PM
- Tevogen Announces Reverse Stock Split • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization • GlobeNewswire Inc. • 02/27/2026 07:20:00 PM
- UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus • GlobeNewswire Inc. • 02/26/2026 09:22:45 PM
- Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus • GlobeNewswire Inc. • 02/26/2026 02:20:00 PM
- Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders • GlobeNewswire Inc. • 01/30/2026 08:00:00 PM
- Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue • GlobeNewswire Inc. • 01/29/2026 07:45:00 PM
- Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025 • GlobeNewswire Inc. • 01/12/2026 02:00:00 PM
- Tevogen CEO Donates Shares to Support Education for Underprivileged Children • GlobeNewswire Inc. • 12/22/2025 05:40:00 PM
- Tevogen CEO Donates Personal Shares to Support Local Fire Department • GlobeNewswire Inc. • 12/19/2025 04:10:00 PM
- Tevogen CEO Supports Local Law Enforcement with Personal Contribution of 230,000 Company’s Shares of Common Stock • GlobeNewswire Inc. • 12/11/2025 08:15:00 PM
- Tevogen Celebrates Board Member Dr. Curtis Patton, Honored by Yale University for Distinguished Career and Lasting Contributions to Medical Education and Equity in Medicine • GlobeNewswire Inc. • 12/09/2025 07:20:00 PM
- Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook • GlobeNewswire Inc. • 12/08/2025 07:50:00 PM
- Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q • GlobeNewswire Inc. • 11/14/2025 07:32:37 PM
- Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID • GlobeNewswire Inc. • 11/05/2025 08:20:00 PM
- Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn • GlobeNewswire Inc. • 11/03/2025 07:45:00 PM
